Barchart is a leading provider of market data and services to the global financial, media, and commodity industries. From our interactive charting library, through to our leading financial analysis desktops, we connect you to the content you need.
| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 48.68 +14.05% on 03/01/16 |
Period Open: 47.94
| 60.87 -8.79% on 03/07/16 | +7.58 (+15.81%) since 02/29/16 |
| 3-Month | 34.87 +59.22% on 01/12/16 |
Period Open: 39.48
| 60.87 -8.79% on 03/07/16 | +16.04 (+40.63%) since 12/29/15 |
| 52-Week | 34.87 +59.22% on 01/12/16 |
Period Open: 51.23
| 60.87 -8.79% on 03/07/16 | +4.29 (+8.37%) since 03/27/15 |
The dollar index (DXY00 ) Wednesday fell by -0.92%. The dollar was under pressure Wednesday as the tit-for-tat trade war with China erodes confidence in the dollar after the US government barred Nvidia...
Copper will prescribe what comes next for safe-haven assets like gold and silver as well as the broader market.
Silver Completes A Higher Degree Correction and its Now Eyeing 36-37 Target area from technical and Elliott wave perspective.
The dollar index (DXY00 ) today is down by -0.70%. The dollar is under pressure today as the tit-for-tat trade war with China erodes confidence in the dollar after the US government barred Nvidia from...
Safe-haven demand is back on the radar as gold and silver climb overnight. Phil Streible breaks down what’s driving the move and what key levels to watch next in today’s Metals Minute.
Here are the European commodity winners and losers to watch this week.
The dollar index (DXY00 ) Tuesday rose by +0.53%. The dollar Tuesday rose moderately on better-than-expected US economic news on Apr Empire manufacturing survey general business conditions and the Mar...
The dollar index (DXY00 ) today is up by +0.42%. The dollar today is moderately higher on better-than-expected US economic news on Apr Empire manufacturing survey general business conditions and the Mar...
Phil Streible dives into the shift in sentiment around gold as outflows begin to emerge. Is this a healthy pullback—or a sign of something bigger? Tune in to today’s Metals Minute for the full breakdown....
The dollar index (DXY00 ) Monday fell by -0.49% and is just above last Friday’s 3-year low. The dollar posted moderate losses Monday as a stock rebound curbed liquidity demand for the dollar. The dollar...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
P-MUC1C-ALLO1 and P-BCMA-ALLO1 were well tolerated, with no dose-limiting toxicities (DLTs), cytokine release syndrome (CRS), graft vs host disease (GVHD) or...
| 3rd Resistance Point | N/A |
| 2nd Resistance Point | 55.52 |
| 1st Resistance Point | 55.52 |
| Last Price | 55.52s |
| 1st Support Level | 55.52 |
| 2nd Support Level | 55.52 |
| 3rd Support Level | N/A |
| 52-Week High | 60.87 |
| Last Price | 55.52s |
| Fibonacci 61.8% | 50.94 |
| Fibonacci 50% | 47.87 |
| Fibonacci 38.2% | 44.80 |
| 52-Week Low | 34.87 |
